MedPath

Benefits of Analgesia Nociception Index Guided Fentanyl administration in critically ill patient: A randomized controlled trial

Phase 2
Conditions
more than 18-year intubated patient in intensive care unit who required intravenous anesthetic drug and fentanyl.
intubated patient, opioid consumption, pain assessment, analgesia Nociception Index, ANI, sedation in intensive care unit
Registration Number
TCTR20221031002
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
nknown
Sex
All
Target Recruitment
50
Inclusion Criteria

1. More than 18-year intubated patient admitted to intensive care unit with.
2. Required intravenous anesthetic drug and fentanyl for sedate.
3. Accept to participate in the research project and sign a letter of consent to participate in the research project.

Exclusion Criteria

1. Patient with unstable hemodynamic requiring high dose of vasopressor
2. Patient with cardiac arrythmia
3. Patient with chronic opioid used
4. Patient with autonomic dysfunction
5. Patient with allergic to study drug
6. Patient refuse to participate in research projects or withdraw from research.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
fentanyl consumption at 48 h at 48 h after enrollment ANI
Secondary Outcome Measures
NameTimeMethod
Correlation of pain measurement at 4,8,12,16,20,24,28,32,36.40,44 and 48 h after enrolled ANI and BPS score,Association of side effects from the use of analgesics with the amount of analgesics used. ICU stayed CAM-ICU, withdrawal symptom
© Copyright 2025. All Rights Reserved by MedPath